Early-stage breast cancer patients with HER2 positive tumors at increased risk of rec

[News]

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

More... (http://www.news-medical.net/?id=44166)